Marleen van Loenen

Marleen Van Loenen is an accomplished professional in the field of immunology and nonclinical development with a career spanning over two decades. Currently serving as Executive Director of Next-Gen Technologies at T-knife Therapeutics since May 2023, Marleen previously held significant roles at MeiraGTx Netherlands B.V. as Senior Director and Head of Nonclinical Development from May 2020 to May 2023. Marleen's experience includes directing nonclinical development at Gadeta B.V. and notable contributions as a senior scientist, focusing on TEG programs and preclinical models. Academic achievements include postdoctoral research at Sanquin Bloedvoorziening and Leiden University Medical Center, where Marleen was involved in T-cell engineering and clinical trial management. Educational qualifications include a PhD in Immunology from Leiden University Medical Center and a Master of Science in Biomedical Sciences from Leiden University.